Prescription opioid abuse is a worldwide growing significant health problem. For that reason, the manufacturing of abuse-deterrent dosage forms is highly important. Alcohol is likely to interact with the drug product and causes a sudden drug liberation (i.e., dose dumping), which possibly results in dangerous side effects and poses a serious safety concern. Thus, it is necessary to develop robust dosage forms that are resistant to the effects of various ethanol concentrations in order to eliminate the risk of immediate release of the entire opioid dose. In this article we review the current information available for drug products and existing formulation strategies that prevent both drug abuse and ethanol-induced dose dumping. These studies may provide insight into how various technologies may differ in their ability to deter opiate drugs abuse.

Katedra farmaceutickej chémie Farmaceutická fakulta Univerzita Komenského Bratislava Slovensko

Saneca Pharmaceuticals a s Hlohovec Slovensko

Formulation of abuse-resistant opiates drug dosage forms

Literatura

000      

00000naa a2200000 a 4500

001      

bmc20017203

003      

CZ-PrNML

005      

20201228172526.0

007      

ta

008      

201101s2020 xr f 000 0|slo||

009      

AR

040    __

$a ABA008 $d ABA008 $e AACR2 $b cze

041    0_

$a slo $b eng

044    __

$a xr

100    1_

$a Husár, Štefan $7 xx0253553 $u Katedra farmaceutickej chémie, Farmaceutická fakulta, Univerzita Komenského, Bratislava, Slovensko; Saneca Pharmaceuticals a.s., Hlohovec, Slovensko

245    10

$a Formulácia opiátových liekových foriem odolných voči zneužívaniu / $c Š. Husár, M. Sýkorová, K. Rumlová, K. Chomaničová, B. Vladovičová, A. Bednárová

246    31

$a Formulation of abuse-resistant opiates drug dosage forms

504    __

$a Literatura

520    9_

$a Prescription opioid abuse is a worldwide growing significant health problem. For that reason, the manufacturing of abuse-deterrent dosage forms is highly important. Alcohol is likely to interact with the drug product and causes a sudden drug liberation (i.e., dose dumping), which possibly results in dangerous side effects and poses a serious safety concern. Thus, it is necessary to develop robust dosage forms that are resistant to the effects of various ethanol concentrations in order to eliminate the risk of immediate release of the entire opioid dose. In this article we review the current information available for drug products and existing formulation strategies that prevent both drug abuse and ethanol-induced dose dumping. These studies may provide insight into how various technologies may differ in their ability to deter opiate drugs abuse.

650    _2

$a lidé $7 D006801

650    12

$a zneužívání léčiv $x prevence a kontrola $7 D000076064

650    _2

$a opioidní analgetika $x farmakokinetika $7 D000701

650    _2

$a uvolňování léčiv $7 D065546

650    _2

$a lékové formy $7 D004304

700    1_

$a Sýkorová, Miroslava $7 xx0100566 $u Katedra farmaceutickej chémie, Farmaceutická fakulta, Univerzita Komenského, Bratislava, Slovensko

700    1_

$a Rumlová, Katarína $7 xx0253528 $u Katedra farmaceutickej chémie, Farmaceutická fakulta, Univerzita Komenského, Bratislava, Slovensko

700    1_

$a Chomaničová, Kamila, $d 1995- $7 xx0253561 $u Katedra farmaceutickej chémie, Farmaceutická fakulta, Univerzita Komenského, Bratislava, Slovensko

700    1_

$a Vladovičová, Beáta $7 xx0253532 $u Saneca Pharmaceuticals a.s., Hlohovec, Slovensko

700    1_

$a Bednárová, Adriana $7 xx0253534 $u Saneca Pharmaceuticals a.s., Hlohovec, Slovensko

773    0_

$t Chemické listy $x 0009-2770 $g Roč. 114, č. 6 (2020), s. 389-394 $w MED00011010

856    41

$u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/3618/3561 $y plný text volně přístupný

910    __

$a ABA008 $b B 1918 $c 395 $y p $z 0

990    __

$a 20201030100552 $b ABA008

991    __

$a 20201228172525 $b ABA008

999    __

$a ok $b bmc $g 1578197 $s 1107389

BAS    __

$a 3

BMC    __

$a 2020 $b 114 $c 6 $d 389-394 $i 0009-2770 $m Chemické listy $x MED00011010

LZP    __

$c NLK109 $d 20201228 $a NLK 2020-10/jt